查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1446559

动态血压监测设备市场规模、份额、趋势分析报告：按产品类型、最终用途、地区和细分市场预测，2024-2030 年

Ambulatory Blood Pressure Monitoring Devices Market Size, Share & Trends Analysis Report By Product, By Type, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 60 Pages | 商品交期: 2-10个工作天内

价格

动态血压监测设备市场成长与趋势：

Grand View Research, Inc.最新研究显示，预计2030年全球动态血压监测设备市场规模将达到18.7亿美元，2024年至2030年复合年增长率为8.45%。

加速该市场成长的驱动力包括老年人口的增加、高血压等慢性病的流行以及全球技术的进步。根据世界卫生组织公布的统计数据，估计约有11.3亿人患有高血压，每年有760万人死亡。

此外，在过去的十年中，高血压已成为出血性中风和冠状动脉心臟病的主要危险因子。例如，根据世界卫生组织的数据，全球估计有12.8亿30岁至79岁的成年人患有高血压，但42.0%的高血压成年人不知道自己患有高血压。我没有。高血压不仅是最普遍的疾病，也是心血管疾病、过早死亡和残疾的主要原因。这也是一笔庞大的经济负担。

人口老化也是加速市场成长的因素。根据世界卫生组织2022年10月发布的最新资料，到2030年，全球六分之一的人将超过60岁，到2050年，数字将翻倍。此外，心血管疾病在老年族群中非常普遍。

此外，动态血压监测（ABPM）设备的技术进步可能会在预测期内提振市场。基于数位技术的行动血压计的製造正在刺激消费者的需求。新兴市场的主要参与者始终致力于开发成本友善、创新且易于使用的设备，预计这将增强市场需求。

动态血压监测设备市场报告亮点

  • 按产品划分，由于穿戴式技术、应用程式、行动改进、易于存取和易用性等技术不断进步，设备和配件占据市场主导地位，2023 年将占全球收益的 67.5%。
  • 按类型划分，由于血压袖带提供的高精度、资料收集的可靠性和使用的弹性，血压袖带细分市场在 2023 年以 56.3% 的收益占有率占据主导地位。
  • 按最终用途划分，由于住院时间缩短和成本降低，门诊手术数量增加，2023 年门诊手术中心和诊所在 ABPM 设备市场中占据最大份额，为 63.7%。
  • 按地区划分，由于主要企业不断增加产品推出、整体医疗保健支出不断增加以及多项监管部门的核准，北美将在 2023 年占据全球 ABPM 设备市场的主导地位，收益占有率将达到 39.5%。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章动态血压监测设备市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场机会分析
  • 动态血压监测设备市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析
  • 动态血压监测设备市场：区域普及资料
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲 (MEA)

第四章门诊血压监测设备市场：产品评估及趋势分析

  • 2023年及2030年产品市场占有率
  • 细分仪表板
  • 全球动态血压监测设备市场展望（按产品）
  • 2018年至2030年市场规模、预测与趋势分析

第五章门诊血压监测设备市场：类型估计与趋势分析

  • 类型市场占有率，2023 年和 2030 年
  • 细分仪表板
  • 按类型分類的全球动态血压监测设备市场展望
  • 2018年至2030年市场规模、预测与趋势分析

第六章动态血压监测设备市场：最终用途估计与趋势分析

  • 2023 年及 2030 年最终用途市场占有率
  • 细分仪表板
  • 按最终用途分類的全球动态血压监测设备市场前景
  • 2018年至2030年市场规模、预测与趋势分析

第七章门诊血压监测设备市场：区域估计与趋势分析

  • 2023 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 全球区域市场概况
  • 2018-2030年市场规模及预测趋势分析：
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商形势
    • List of key distributors and channel partners
    • Key customers
    • Key company market share analysis, 2023
    • Omron Healthcare Welch Allyn, Inc.
    • A&D Medical Inc.
    • Microlife Corporation
    • Daray Medical
    • Withings
    • Briggs Healthcare
    • GE Healthcare
    • Rossmax International Ltd.
    • GF Health Products Inc
    • Spacelabs Healthcare Inc.
    • Philips Healthcare
    • Biobeat
    • Spacelabs Healthcare Inc
    • Bosch &Sohn GmbH &Co. KG
    • GE Company,
    • Schiller AG
    • DAIFUKU CO. LTD
Product Code: GVR-4-68040-206-0

Ambulatory Blood Pressure Monitoring Devices Market Growth & Trends:

The global ambulatory blood pressure monitoring devices market size is expected to reach USD 1.87 billion by 2030, expanding at a CAGR of 8.45% from 2024 to 2030, according to a new study by Grand View Research, Inc. The driving factors accelerating the growth of this market include the increasing geriatric population, the prevalence of chronic disorders such as hypertension, and technological advancement worldwide. According to the statistics published by WHO, around 1.13 billion people are likely to suffer from hypertension and causing 7.6 million deaths annually.

In addition, high blood pressure is a major risk factor for hemorrhagic stroke and coronary heart disease in this decade. For instance, as per WHO, an estimated 1.28 billion adults who are aged between 30-79 years globally suffer from hypertension, whereas 42.0% of the adults having hypertension are not aware that they have the condition. Hypertension, besides being the most prevalent, is also the leading cause of cardiovascular disease, premature mortality, and disability. It poses a significant economic burden.

Aging population is another driving factor accelerating the growth of the market. As per the recent WHO statistical data published in October 2022, 1 in 6 people would be over 60 years of age worldwide by 2030 and this number would be doubled by 2050. Moreover, cardiovascular diseases are highly prevalent in the older age population.

Also, technological advancement in ambulatory blood pressure monitoring (ABPM) devices is likely to boost the market over the forecast period. Manufacturing of digital technology-based and mobile blood pressure devices fueling the demand of consumers. Key players in the market consistently focus on the development of cost-friendly, innovative, and easy-to-use devices is likely to strengthen the demand of the market.

Ambulatory Blood Pressure Monitoring Devices Market Report Highlights:

  • Based on the product, instrument & accessories dominated the market and accounted for 67.5 % of global revenue in 2023 owing to constant technological advancements such as improvements in wearable technology, apps, & mobiles, their accessibility, and simplicity in usage
  • Based on the type, the blood pressure cuff segment dominated the market with a revenue share of 56.3% in 2023 due to higher accuracy, reliability of data collection, and flexibility in usage provided by blood cuff
  • Based on the end-use, ambulatory surgical centers & clinics accounted for largest share of 63.7 % of the ABPM devices market in 2023 owing to increasing number of ambulatory surgeries due to short duration of stay and cost savings
  • Based on Based on the region, North America dominated the global ABPM devices market with a revenue share of 39.5 in 2023 owing to increase in product launches by key companies, rising overall healthcare expenditure, and an increase in several regulatory approvals

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Type
    • 1.2.3. End-use
    • 1.2.4. Sales Channel
    • 1.2.5. Regional scope
    • 1.2.6. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in Asia Pacific
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Typeoutlook
    • 2.2.3. End-use outlook
    • 2.2.4. Sales channel outlook
    • 2.2.5. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Ambulatory Blood Pressure Monitoring Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of androgenic alopecia
      • 3.2.1.2. Technological advancements in androgenic alopecia
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Lack of reimbursement policies for androgenic alopecia
    • 3.2.3. Market opportunity analysis
      • 3.2.3.1. Increasing prevalence of chronic diseases
  • 3.3. Ambulatory Blood Pressure Monitoring Devices Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
  • 3.4. Ambulatory Blood Pressure Monitoring Devices Market: Prevalence Data, By Region
    • 3.4.1. North America
      • 3.4.1.1. U.S.
      • 3.4.1.2. Canada
    • 3.4.2. Europe
      • 3.4.2.1. UK
      • 3.4.2.2. Germany
      • 3.4.2.3. France
      • 3.4.2.4. Italy
      • 3.4.2.5. Spain
      • 3.4.2.6. Denmark
      • 3.4.2.7. Sweden
      • 3.4.2.8. Norway
    • 3.4.3. Asia Pacific
      • 3.4.3.1. Japan
      • 3.4.3.2. China
      • 3.4.3.3. India
      • 3.4.3.4. South Korea
      • 3.4.3.5. Australia
      • 3.4.3.6. Thailand
    • 3.4.4. Latin America
      • 3.4.4.1. Brazil
      • 3.4.4.2. Mexico
      • 3.4.4.3. Argentina
    • 3.4.5. Middle East and Africa (MEA)
      • 3.4.5.1. South Africa
      • 3.4.5.2. Saudi Arabia
      • 3.4.5.3. UAE
      • 3.4.5.4. Kuwait

Chapter 4. Ambulatory Blood Pressure Monitoring Devices Market: Product Estimates & Trend Analysis

  • 4.1. Product Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Ambulatory Blood Pressure Monitoring Devices Market by Product Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Ambulatory Blood Pressure Monitors
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Instrument & Accessories
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Ambulatory Blood Pressure Monitoring Devices Market: Type Estimates & Trend Analysis

  • 5.1. Type Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Ambulatory Blood Pressure Monitoring Devices Market by Type Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Blood Pressure Cuffs
      • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Others Type
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Ambulatory Blood Pressure Monitoring Devices Market: End-use Estimates & Trend Analysis

  • 6.1. End-use Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Global Ambulatory Blood Pressure Monitoring Devices Market by End-use Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.4.1. Hospitals
      • 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Homecare
      • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Ambulatory Blood Pressure Monitoring Devices Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
    • 7.5.2. Canada
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
    • 7.6.2. Germany
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
    • 7.6.3. France
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/ reimbursement structure
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
    • 7.6.4. Italy
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework/ reimbursement structure
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
    • 7.6.5. Spain
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework/ reimbursement structure
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
    • 7.6.6. Norway
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework/ reimbursement structure
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
    • 7.6.7. Sweden
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Regulatory framework/ reimbursement structure
      • 7.6.7.3. Competitive scenario
      • 7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
    • 7.6.8. Denmark
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Regulatory framework/ reimbursement structure
      • 7.6.8.3. Competitive scenario
      • 7.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
    • 7.7.2. China
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
    • 7.7.3. India
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
    • 7.7.4. Australia
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
    • 7.7.5. South Korea
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Regulatory framework/ reimbursement structure
      • 7.7.5.3. Competitive scenario
      • 7.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
    • 7.7.6. Thailand
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Regulatory framework/ reimbursement structure
      • 7.7.6.3. Competitive scenario
      • 7.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework/ reimbursement structure
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
    • 7.8.2. Mexico
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework/ reimbursement structure
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
    • 7.8.3. Argentina
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Regulatory framework/ reimbursement structure
      • 7.8.3.3. Competitive scenario
      • 7.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Regulatory framework/ reimbursement structure
      • 7.9.1.3. Competitive scenario
      • 7.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Regulatory framework/ reimbursement structure
      • 7.9.2.3. Competitive scenario
      • 7.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
    • 7.9.3. UAE
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Regulatory framework/ reimbursement structure
      • 7.9.3.3. Competitive scenario
      • 7.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Regulatory framework/ reimbursement structure
      • 7.9.4.3. Competitive scenario
      • 7.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2023
    • 8.3.4. Omron Healthcare Welch Allyn, Inc.
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. A&D Medical Inc.
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Microlife Corporation
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Daray Medical
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Withings
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Briggs Healthcare
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. GE Healthcare
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Rossmax International Ltd.
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. GF Health Products Inc
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. Spacelabs Healthcare Inc.
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives
    • 8.3.14. Philips Healthcare
      • 8.3.14.1. Company overview
      • 8.3.14.2. Financial performance
      • 8.3.14.3. Product benchmarking
      • 8.3.14.4. Strategic initiatives
    • 8.3.15. Biobeat
      • 8.3.15.1. Company overview
      • 8.3.15.2. Financial performance
      • 8.3.15.3. Product benchmarking
      • 8.3.15.4. Strategic initiatives
    • 8.3.16. Spacelabs Healthcare Inc
      • 8.3.16.1. Company overview
      • 8.3.16.2. Financial performance
      • 8.3.16.3. Product benchmarking
      • 8.3.16.4. Strategic initiatives
    • 8.3.17. Bosch & Sohn GmbH & Co. KG
      • 8.3.17.1. Company overview
      • 8.3.17.2. Financial performance
      • 8.3.17.3. Product benchmarking
      • 8.3.17.4. Strategic initiatives
    • 8.3.18. GE Company,
      • 8.3.18.1. Company overview
      • 8.3.18.2. Financial performance
      • 8.3.18.3. Product benchmarking
      • 8.3.18.4. Strategic initiatives
    • 8.3.19. Schiller AG
      • 8.3.19.1. Company overview
      • 8.3.19.2. Financial performance
      • 8.3.19.3. Product benchmarking
      • 8.3.19.4. Strategic initiatives
    • 8.3.20. DAIFUKU CO. LTD
      • 8.3.20.1. Company overview
      • 8.3.20.2. Financial performance
      • 8.3.20.3. Product benchmarking
      • 8.3.20.4. Strategic initiative

List of Tables

  • Table 1. List of abbreviation
  • Table 2. North America Ambulatory Blood Pressure Monitoring Devices Market, by country, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Table 3. North America Ambulatory Blood Pressure Monitoring Devices Market, by Product , 2018 - 2030 (USD Million)
  • Table 4. North America Ambulatory Blood Pressure Monitoring Devices Market, by treatment, 2018 - 2030 (USD Million)
  • Table 5. North America Ambulatory Blood Pressure Monitoring Devices Market, by end-use, 2018 - 2030 (USD Million)
  • Table 6. U.S. Ambulatory Blood Pressure Monitoring Devices Market, by Product , 2018 - 2030 (USD Million)
  • Table 7. U.S. Ambulatory Blood Pressure Monitoring Devices Market, by treatment, 2018 - 2030 (USD Million)
  • Table 8. U.S. Ambulatory Blood Pressure Monitoring Devices Market, by end-use, 2018 - 2030 (USD Million)
  • Table 9. Canada Ambulatory Blood Pressure Monitoring Devices Market, by Product , 2018 - 2030 (USD Million)
  • Table 10. Canada Ambulatory Blood Pressure Monitoring Devices Market, by treatment, 2018 - 2030 (USD Million)
  • Table 11. Canada Ambulatory Blood Pressure Monitoring Devices Market, by end-use, 2018 - 2030 (USD Million)
  • Table 12. Europe Ambulatory Blood Pressure Monitoring Devices Market, by country, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Table 13. Europe Ambulatory Blood Pressure Monitoring Devices Market, by Product , 2018 - 2030 (USD Million)
  • Table 14. Europe Ambulatory Blood Pressure Monitoring Devices Market, by treatment, 2018 - 2030 (USD Million)
  • Table 15. Europe Ambulatory Blood Pressure Monitoring Devices Market, by end-use, 2018 - 2030 (USD Million)
  • Table 16. Germany Ambulatory Blood Pressure Monitoring Devices Market, by Product , 2018 - 2030 (USD Million)
  • Table 17. Germany Ambulatory Blood Pressure Monitoring Devices Market, by treatment, 2018 - 2030 (USD Million)
  • Table 18. Germany Ambulatory Blood Pressure Monitoring Devices Market, by end-use, 2018 - 2030 (USD Million)
  • Table 19. UK Ambulatory Blood Pressure Monitoring Devices Market, by Product , 2018 - 2030 (USD Million)
  • Table 20. UK Ambulatory Blood Pressure Monitoring Devices Market, by treatment, 2018 - 2030 (USD Million)
  • Table 21. UK Ambulatory Blood Pressure Monitoring Devices Market, by end-use, 2018 - 2030 (USD Million)
  • Table 22. France Ambulatory Blood Pressure Monitoring Devices Market, by Product , 2018 - 2030 (USD Million)
  • Table 23. France Ambulatory Blood Pressure Monitoring Devices Market, by treatment, 2018 - 2030 (USD Million)
  • Table 24. France Ambulatory Blood Pressure Monitoring Devices Market, by end-use, 2018 - 2030 (USD Million)
  • Table 25. Italy Ambulatory Blood Pressure Monitoring Devices Market, by Product , 2018 - 2030 (USD Million)
  • Table 26. Italy Ambulatory Blood Pressure Monitoring Devices Market, by treatment, 2018 - 2030 (USD Million)
  • Table 27. Italy Ambulatory Blood Pressure Monitoring Devices Market, by end-use, 2018 - 2030 (USD Million)
  • Table 28. Spain Ambulatory Blood Pressure Monitoring Devices Market, by Product , 2018 - 2030 (USD Million)
  • Table 29. Spain Ambulatory Blood Pressure Monitoring Devices Market, by treatment, 2018 - 2030 (USD Million)
  • Table 30. Spain Ambulatory Blood Pressure Monitoring Devices Market, by end-use, 2018 - 2030 (USD Million)
  • Table 31. Denmark Ambulatory Blood Pressure Monitoring Devices Market, by Product , 2018 - 2030 (USD Million)
  • Table 32. Denmark Ambulatory Blood Pressure Monitoring Devices Market, by treatment, 2018 - 2030 (USD Million)
  • Table 33. Denmark Ambulatory Blood Pressure Monitoring Devices Market, by end-use, 2018 - 2030 (USD Million)
  • Table 34. Sweden Ambulatory Blood Pressure Monitoring Devices Market, by Product , 2018 - 2030 (USD Million)
  • Table 35. Sweden Ambulatory Blood Pressure Monitoring Devices Market, by treatment, 2018 - 2030 (USD Million)
  • Table 36. Sweden Ambulatory Blood Pressure Monitoring Devices Market, by end-use, 2018 - 2030 (USD Million)
  • Table 37. Norway Ambulatory Blood Pressure Monitoring Devices Market, by Product , 2018 - 2030 (USD Million)
  • Table 38. Norway Ambulatory Blood Pressure Monitoring Devices Market, by treatment, 2018 - 2030 (USD Million)
  • Table 39. Norway Ambulatory Blood Pressure Monitoring Devices Market, by end-use, 2018 - 2030 (USD Million)
  • Table 40. Asia Pacific Ambulatory Blood Pressure Monitoring Devices Market, by country, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Table 41. Asia Pacific Ambulatory Blood Pressure Monitoring Devices Market, by Product , 2018 - 2030 (USD Million)
  • Table 42. Asia Pacific Ambulatory Blood Pressure Monitoring Devices Market, by treatment, 2018 - 2030 (USD Million)
  • Table 43. Asia Pacific Ambulatory Blood Pressure Monitoring Devices Market, by end-use, 2018 - 2030 (USD Million)
  • Table 44. China Ambulatory Blood Pressure Monitoring Devices Market, by Product , 2018 - 2030 (USD Million)
  • Table 45. China Ambulatory Blood Pressure Monitoring Devices Market, by treatment, 2018 - 2030 (USD Million)
  • Table 46. China Ambulatory Blood Pressure Monitoring Devices Market, by end-use, 2018 - 2030 (USD Million)
  • Table 47. Japan Ambulatory Blood Pressure Monitoring Devices Market, by Product , 2018 - 2030 (USD Million)
  • Table 48. Japan Ambulatory Blood Pressure Monitoring Devices Market, by treatment, 2018 - 2030 (USD Million)
  • Table 49. Japan Ambulatory Blood Pressure Monitoring Devices Market, by end-use, 2018 - 2030 (USD Million)
  • Table 50. India Ambulatory Blood Pressure Monitoring Devices Market, by Product , 2018 - 2030 (USD Million)
  • Table 51. India Ambulatory Blood Pressure Monitoring Devices Market, by treatment, 2018 - 2030 (USD Million)
  • Table 52. India Ambulatory Blood Pressure Monitoring Devices Market, by end-use, 2018 - 2030 (USD Million)
  • Table 53. South Korea Ambulatory Blood Pressure Monitoring Devices Market, by Product , 2018 - 2030 (USD Million)
  • Table 54. South Korea Ambulatory Blood Pressure Monitoring Devices Market, by treatment, 2018 - 2030 (USD Million)
  • Table 55. South Korea Ambulatory Blood Pressure Monitoring Devices Market, by end-use, 2018 - 2030 (USD Million)
  • Table 56. Australia Ambulatory Blood Pressure Monitoring Devices Market, by Product , 2018 - 2030 (USD Million)
  • Table 57. Australia Ambulatory Blood Pressure Monitoring Devices Market, by treatment, 2018 - 2030 (USD Million)
  • Table 58. Australia Ambulatory Blood Pressure Monitoring Devices Market, by end-use, 2018 - 2030 (USD Million)
  • Table 59. Thailand Ambulatory Blood Pressure Monitoring Devices Market, by Product , 2018 - 2030 (USD Million)
  • Table 60. Thailand Ambulatory Blood Pressure Monitoring Devices Market, by treatment, 2018 - 2030 (USD Million)
  • Table 61. Thailand Ambulatory Blood Pressure Monitoring Devices Market, by end-use, 2018 - 2030 (USD Million)
  • Table 62. Latin America Ambulatory Blood Pressure Monitoring Devices Market, by country, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Table 63. Latin America Ambulatory Blood Pressure Monitoring Devices Market, by Product , 2018 - 2030 (USD Million)
  • Table 64. Latin America Ambulatory Blood Pressure Monitoring Devices Market, by treatment, 2018 - 2030 (USD Million)
  • Table 65. Latin America Ambulatory Blood Pressure Monitoring Devices Market, by end-use, 2018 - 2030 (USD Million)
  • Table 66. Brazil Ambulatory Blood Pressure Monitoring Devices Market, by Product , 2018 - 2030 (USD Million)
  • Table 67. Brazil Ambulatory Blood Pressure Monitoring Devices Market, by treatment, 2018 - 2030 (USD Million)
  • Table 68. Brazil Ambulatory Blood Pressure Monitoring Devices Market, by end-use, 2018 - 2030 (USD Million)
  • Table 69. Mexico Ambulatory Blood Pressure Monitoring Devices Market, by Product , 2018 - 2030 (USD Million)
  • Table 70. Mexico Ambulatory Blood Pressure Monitoring Devices Market, by treatment, 2018 - 2030 (USD Million)
  • Table 71. Mexico Ambulatory Blood Pressure Monitoring Devices Market, by end-use, 2018 - 2030 (USD Million)
  • Table 72. Argentina Ambulatory Blood Pressure Monitoring Devices Market, by Product , 2018 - 2030 (USD Million)
  • Table 73. Argentina Ambulatory Blood Pressure Monitoring Devices Market, by treatment, 2018 - 2030 (USD Million)
  • Table 74. Argentina Ambulatory Blood Pressure Monitoring Devices Market, by end-use, 2018 - 2030 (USD Million)
  • Table 75. MEA Ambulatory Blood Pressure Monitoring Devices Market, by country, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Table 76. MEA Ambulatory Blood Pressure Monitoring Devices Market, by Product , 2018 - 2030 (USD Million)
  • Table 77. MEA Ambulatory Blood Pressure Monitoring Devices Market, by treatment, 2018 - 2030 (USD Million)
  • Table 78. MEA Ambulatory Blood Pressure Monitoring Devices Market, by end-use, 2018 - 2030 (USD Million)
  • Table 79. South Africa Ambulatory Blood Pressure Monitoring Devices Market, by Product , 2018 - 2030 (USD Million)
  • Table 80. South Africa Ambulatory Blood Pressure Monitoring Devices Market, by treatment, 2018 - 2030 (USD Million)
  • Table 81. South Africa Ambulatory Blood Pressure Monitoring Devices Market, by end-use, 2018 - 2030 (USD Million)
  • Table 82. Saudi Arabia Ambulatory Blood Pressure Monitoring Devices Market, by Product , 2018 - 2030 (USD Million)
  • Table 83. Saudi Arabia Ambulatory Blood Pressure Monitoring Devices Market, by treatment, 2018 - 2030 (USD Million)
  • Table 84. Saudi Arabia Ambulatory Blood Pressure Monitoring Devices Market, by end-use, 2018 - 2030 (USD Million)
  • Table 85. UAE Ambulatory Blood Pressure Monitoring Devices Market, by Product , 2018 - 2030 (USD Million)
  • Table 86. UAE Ambulatory Blood Pressure Monitoring Devices Market, by treatment, 2018 - 2030 (USD Million)
  • Table 87. UAE Ambulatory Blood Pressure Monitoring Devices Market, by end-use, 2018 - 2030 (USD Million)
  • Table 88. Kuwait Ambulatory Blood Pressure Monitoring Devices Market, by Product , 2018 - 2030 (USD Million)
  • Table 89. Kuwait Ambulatory Blood Pressure Monitoring Devices Market, by treatment, 2018 - 2030 (USD Million)
  • Table 90. Kuwait Ambulatory Blood Pressure Monitoring Devices Market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Ambulatory Blood Pressure Monitoring Devices Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Value chain based sizing & forecasting
  • Fig. 6 QFD modelling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 Market dynamics
  • Fig. 11 Prevalence of rheumatoid arthritis in 2022, by WHO regions
  • Fig. 12 Porter's five forces analysis
  • Fig. 13 PESTLE analysis
  • Fig. 14 Ambulatory Blood Pressure Monitoring Devices Market: Products outlook and key takeaways
  • Fig. 15 Ambulatory Blood Pressure Monitoring Devices Market: Product movement analysis
  • Fig. 16 Ambulatory blood pressure monitors market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 Instrument & accessories market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 Ambulatory Blood Pressure Monitoring Devices Market: Type outlook and key takeaways
  • Fig. 19 Ambulatory Blood Pressure Monitoring Devices Market: Type movement analysis
  • Fig. 20 Blood Pressure Cuffs market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Others market estimates and forecast, 2018 - 2030, USD Million
  • Fig. 22 Ambulatory Blood Pressure Monitoring Devices Market: End-use outlook and key takeaways
  • Fig. 23 Ambulatory Blood Pressure Monitoring Devices Market: End-use movement analysis
  • Fig. 24 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Ambulatory Surgical Centers & Clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Home-care settings market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Provincial marketplace: Key takeaways (1/2)
  • Fig. 28 Provincial marketplace: Key takeaways (2/2)
  • Fig. 29 North America Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 30 Key country dynamics
  • Fig. 31 U.S. ambulatoryblood pressure monitoring market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 32 Key country dynamics
  • Fig. 33 Canada ambulatoryblood pressure monitoring market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 34 Europe Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 35 Key country dynamics
  • Fig. 36 UK Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 37 Key country dynamics
  • Fig. 38 Germany Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 39 Key country dynamics
  • Fig. 40 France Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 41 Key country dynamics
  • Fig. 42 Spain Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 43 Key country dynamics
  • Fig. 44 Italy Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 45 Key country dynamics
  • Fig. 46 Denmark Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 47 Key country dynamics
  • Fig. 48 Sweden Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 49 Key country dynamics
  • Fig. 50 Norway Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 51 Rest of Europe Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030, (USD million) (Number of Patients Treated in Thousands)
  • Fig. 52 Asia Pacific ambulatory blood pressure monitoring market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 53 Key country dynamics
  • Fig. 54 Reimbursement scenario
  • Fig. 55 Japan Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 56 Key country dynamics
  • Fig. 57 Regulatory framework
  • Fig. 58 Reimbursement scenario
  • Fig. 59 China Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 60 Key country dynamics
  • Fig. 61 Reimbursement scenario
  • Fig. 62 India ambulatory blood pressure monitoring market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 63 Key country dynamics
  • Fig. 64 Australia Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 65 Key country dynamics
  • Fig. 66 South Korea Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 -2030, (USD million) (Number of Patients Treated in Thousands)
  • Fig. 67 Key country dynamics
  • Fig. 68 Thailand ambulatoryblood pressure monitoring market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 69 Key country dynamics
  • Fig. 70 Malaysia Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 71 Key country dynamics
  • Fig. 72 Vietnam Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 73 Key country dynamics
  • Fig. 74 Philippines Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 75 Rest of Asia Pacific Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030, (USD million) (Number of Patients Treated in Thousands)
  • Fig. 76 Latin America Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 77 Key country dynamics
  • Fig. 78 Brazil regulation details
  • Fig. 79 Reimbursement scenario
  • Fig. 80 Brazil Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 81 Key country dynamics
  • Fig. 82 Argentina pharmaceuticals registration details
  • Fig. 83 Argentina Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 84 Key country dynamics
  • Fig. 85 Regulatory framework
  • Fig. 86 Reimbursement scenario
  • Fig. 87 Mexico Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 88 Rest of Latin America Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030, (USD million) (Number of Patients Treated in Thousands)
  • Fig. 89 MEA Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030, (USD million)
  • Fig. 90 Key country dynamics
  • Fig. 91 South Africa Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 92 Key country dynamics
  • Fig. 93 Saudi Arabia Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 94 Key country dynamics
  • Fig. 95 UAE Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 96 Key country dynamics
  • Fig. 97 Kuwait Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 98 Key country dynamics
  • Fig. 99 Turkey Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 100 Rest of MEA Ambulatory Blood Pressure Monitoring Devices Market estimates and forecasts, 2018 - 2030 (USD Million) (Number of Patients Treated in Thousands)
  • Fig. 101 Company market share analysis, 2023
  • Fig. 102 Strategic framework